SCHEMBL5200207

SCHEMBL5200207

O=S(=O)(c1ccc(Cl)cc1)C(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
CYP3A4 P08684 1/20 0.54
MAPK1 P28482 1/20 0.54
CA2 P00918 6/20 0.50
CA1 P00915 5/20 0.50
CA12 O43570 4/20 0.50
CA9 Q16790 4/20 0.50
CA14 Q9ULX7 4/20 0.50
CA3 P07451 3/20 0.50
CA4 P22748 3/20 0.50
CA6 P23280 3/20 0.50
CA5A P35218 3/20 0.50
CA7 P43166 3/20 0.50
CA13 Q8N1Q1 3/20 0.50
CA5B Q9Y2D0 3/20 0.50
PSEN1 P49768 2/20 0.47
PSEN2 P49810 2/20 0.47
APH1B Q8WW43 2/20 0.47
NCSTN Q92542 2/20 0.47
APH1A Q96BI3 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043678 0.81 ALDH1A1 (0.48) ALDH1A1EPAS1HPGDALOX15HSD17B10
SCHEMBL9732244 0.78 CA1 (0.46) ALDH1A1CA2CA1PSEN1PSEN2
SCHEMBL12695013 0.77 ALDH1A1 (0.47) ALDH1A1CA2CA1CA12CA9
SCHEMBL752935 0.76 ALDH1A1 (0.54) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL2149310 0.76 TSHR (0.54) ALDH1A1CYP3A4CA2CA1CA12
SCHEMBL536323 0.76 ALDH1A1 (0.54) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL6729425 0.76 MMP2 (0.53) ALDH1A1CA2CA1CA12CA9
SCHEMBL23057068 0.76 CA1 (0.47) ALDH1A1CA2CA1CA12CA9
SCHEMBL8794134 0.76 LMNA (0.52) ALDH1A1CA2CA1CA12CA9
SCHEMBL25187156 0.76 NPC1 (0.40) ALDH1A1CA12CA14MMP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed
US-5175302-A Nucleophilic fluoroalkylation of aldehydes ETHYL CORPORATION (US) 1992-12-29 US disclosed
US-4999429-A Process for the preparation of α,α,β-1-trifluoro-1-olefinic derivatives ETHYL CORPORATION (US) 1991-03-12 US disclosed
US-4837327-A Process for nucleophilic fluoroalkylation of aldehydes ETHYL CORPORATION (US) 1989-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 ALDH1A1 204/4885CYP3A4 749/4885MAPK1 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.